INS and type 1 diabetes mellitus: Eleven adult patients with long-standing T1D, who were using the Tandem t:slim X2 insulin pump with Control-IQ technology (Tandem Diabetes Care, Inc., San Diego, CA, USA) and received tirzepatide as a non-insulin adjunct therapy, were included in the analysis.